Clinical Trial Update: Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma [NA]

View source ↗

Summary

A completed Stanford University clinical trial evaluating enrichment and purging of stem cells in non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Lymphoma, Non-Hodgkin | NA | Status: COMPLETED